Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke

Int J Stroke. 2016 Aug;11(6):646-55. doi: 10.1177/1747493016641949. Epub 2016 Apr 12.

Abstract

Background: Prediction of recanalization after intravenous thrombolysis could be important to direct secondary reperfusion techniques. Factor seven activating protease (FSAP) has been described to have a relevant pathophysiological role in stroke.

Aim: The aim is to determine whether plasma FSAP levels are associated with recanalization after tissue plasminogen activator in acute stroke.

Methods: FSAP antigen, activity, and FSAP-inhibitor complexes were measured in 120 acute stroke patients admitted to Hospital Vall d'Hebron with arterial occlusions, before intravenous thrombolysis. Recanalization was assessed by transcranial Doppler 2 h after thrombolysis. Predictors of recanalization were determined by logistic regression analysis and the additional predictive value of FSAP over them was determined by integrated discrimination improvement index.

Results: Complete recanalization was achieved in 31 patients. FSAP antigen levels were lower in patients achieving recanalization (8.2 (6.3-11.7) µg/mL vs. 9.8 (7.6-12.8) µg/mL; p = 0.046). After adjustment by age, sex, and National Institutes of Health Stroke Scale, Oxfordshire Community Stroke Project (odds ratio = 0.33 (0.13-0.82), p = 0.017) and FSAP antigen (odds ratio = 3.22 (1.22-8.47), p = 0.018) were independently associated with recanalization, and the addition of FSAP improved the model discrimination (integrated discrimination improvement = 5.5% (1.4-9.7), p = 0.009).

Conclusions: Our study showed that lower FSAP antigen plasma levels were associated with a higher chance of arterial recanalization after tissue plasminogen activator treatment, suggesting an involvement of FSAP in tissue plasminogen activator-induced clot lysis. FSAP antigen determination might be useful in predicting tissue plasminogen activator response in stroke patients.

Keywords: Stroke; factor VII activating protease; hemostasis; outcome; recanalization; thrombolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Brain Ischemia / blood
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / drug therapy*
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Serine Endopeptidases / blood*
  • Severity of Illness Index
  • Stroke / blood
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Thrombolytic Therapy
  • Treatment Outcome
  • Ultrasonography, Doppler, Transcranial

Substances

  • Biomarkers
  • Fibrinolytic Agents
  • HABP2 protein, human
  • Serine Endopeptidases